Customer News Letter
Released
Released
Announcement PDF
Page 1 of 6
June 2015
No Images? Click here
Welcome to our June 2015 newsletter. In this issue we have some latest news
from the clinical community, details of exciting developments in our R&D
department and some new Resonance Health faces to introduce. We hope you
enjoy the update and welcome any comments at info@resonancehealth.com
Customer Focus: LIC-NET Italy Advances Best
Practice in Iron Monitoring
The innovative Liver Iron Cutino Network (LIC-NET) is a growing network of 12
Italian hospitals dedicated to improving the management of iron overload in patients
through standardised assessment of Liver Iron Concentration (LIC) by FerriScan
R2-MRI.
A congress was held in Palermo in May to present new data from the network and
for participants to share experiences of using FerriScan and compare other MRIbased methodologies for measuring LIC.
The advantages of FerriScan over other methods and the critical importance of
standardisation to ensure integrity of data within the network were highlighted.
Network Head, Professor Aurelio Maggio (Director of the Department of
Haematology and Oncology at Villa Sofia-Cervello Hospital, Palermo, Italy)
commented on the crucial role of FerriScan within the project:
“Liver damage is emerging as one of the main issues in Thalassemia Major and
other Hemoglobinopathies. The LIC-NET project tries to answer this problem,
allowing to have the same methodology for determining at national and international
level."
Resonance Health is proud to be involved in this visionary project focussed on
building an international network for using and sharing the FerriScan R2-MRI
method for accurate determination of LIC in all secondary iron overload settings.
https://remote.ferriscan.com/owa/?ae=Item&t=IPM.Note&id=RgAAAACaQFEzIhX6... 19/06/2015
Page 2 of 6
Click for further details...
Participants at the LIC-NET Congress in Palermo led by Prof. Maggio
R&D Round-up
US CHOA Study: Addressing Fatty Liver Disease in Children Using
HepaFat-Scan®
The prestigious Children’s Hospital of Atlanta has confirmed its collaboration with
Resonance Health in a study to validate the use of HepaFat-Scan in a paediatric
patient population.
Click for further details...
Fibrosis Progress and CSIRO Partnership
Chief Scientific Officer Prof. Tim St Pierre has submitted an abstract to the
American Association for the Study of Liver Disease (AASLD) with promising
results from a prototype liver fibrosis measurement that distinguishes between low
and high fibrosis scores in a patient cohort with Hepatitis C.
Sander Bangma, Resonance Health's General Manager said:
“Reaching this stage of development for a fibrosis measurement is an exciting
achievement and we are currently working to obtain new data to test the
technology in a variety of clinical scenarios. We look forward to updating the
market further on collaborations we are undertaking to turn this prototype model
into a clinical tool.”
Click for further details...
In a drive for constant innovation in research and product development, Resonance
Health is also pleased to confirm engagement with the Commonwealth Scientific
and Industrial Research Organisation (CSIRO).
Click for further details...
https://remote.ferriscan.com/owa/?ae=Item&t=IPM.Note&id=RgAAAACaQFEzIhX6... 19/06/2015
Page 3 of 6
US Customer Relations
US customers constitute a significant part of Resonance Health’s customer base,
with 22% of all FerriScans performed there in 2014. In May 2015, company
representatives Angeli Malkani and Andrew Bathgate visited a number of our
valued US sites to get feedback on the FerriScan service, assess its further
potential and introduce HepaFat-Scan to key clinicians.
Angeli Malkani, Global Brand Manager said:
"The feedback was very positive and also provided valuable market intelligence to
inform efforts to grow our presence in the USA. Following this trip we are also
delighted to welcome Sheila Murphy, Resonance Health’s new US-based
consultant on board. Over the coming months Sheila will be engaging with key
stakeholders from the clinical and patient communities to identify demand and
expand our network in the US.”
FerriScan Funding Signals End to Liver Biopsy
for Scottish Haemoglobinopathy Patients
The Scottish Paediatric and Adult Haemoglobinopathies Network has secured
central funding from the Scottish National Services Directorate for Adult patients to
access FerriScan.
This
follows
funding
of
a
national
Paediatric
FerriScan
service
for
haemoglobinopathy patients which is based at Yorkhill Hospital in Glasgow.
Dr Beverley Robertson, Haematologist at Aberdeen Royal Infirmary, and Lead
Clinician of the Scottish Paediatric and Adult Haemoglobinopathy Network,
commented on the achievement:
https://remote.ferriscan.com/owa/?ae=Item&t=IPM.Note&id=RgAAAACaQFEzIhX6... 19/06/2015
Page 4 of 6
“We have a relatively small number of patients with haemoglobinopathies in
Scotland but strive to provide the best quality of care for our patients. We feel it is
important that all patients have equitable access to services and treatments as
recommended in current guidelines.
FerriScan provides the most accurate and standardised MRI tool for measuring
Liver Iron Concentration in our patients and we are delighted to have secured
central funding for the service to benefit health outcomes throughout our network.”
Alliance Medical Sites at Albyn and Forth Valley in Scotland are now FerriScan
certified to provide further access points for the service.
Click for further details...
Alliance Medical - Albyn Hospital:
Teresa Ross (Administration Assistant) & Annette Dahl (MRI Unit Manager)
EASL Abstract Sparks HepaFat-Scan Interest
Chief Scientific Officer, Prof. Tim St Pierre presented an abstract providing the
latest data on HepaFat-Scan at the recent EASL conference in Vienna attended by
10,000 delegates.
Click for further details and to read the abstract...
https://remote.ferriscan.com/owa/?ae=Item&t=IPM.Note&id=RgAAAACaQFEzIhX6... 19/06/2015
Page 5 of 6
Team Member in
Focus: Melanie
Baxter, Marketing
Director
New Faces
Susanna Katay-Davies M.D.
+ , - ffice
s. sanna/ 0 resonancehea1 th.com
2 4 4 4 0 5 6 52 66 6 50 0 6
Melanie Baxter has worked for
Resonance Health since 2005
and now leads global marketing
activities to profile our worldleading MRI technologies and
increase access to these within
the clinical community. With 22
years of strategic communication
experience particularly in the
medical sector, Melanie has
developed an international
network of contacts in the clinical
and patient communities. She
enjoys working closely with our
stakeholders at multiple levels to
gain an in-depth understanding
of their requirements so we can
deliver the most effective
solutions.
Sheila Murphy MBA
+ 7 - ffice
shei1 am 0 resonancehea1 th.com
2 1 310 6 10 9656
Living in Australia for 6 years,
she swapped the sunshine for
the rain several years ago and
now resides with her family in
the beautiful Yorkshire Dales in
the UK. Outside work she enjoys
creative pursuits including art,
culture, creative writing and
composing music.
https://remote.ferriscan.com/owa/?ae=Item&t=IPM.Note&id=RgAAAACaQFEzIhX6... 19/06/2015
Page 6 of 6
Melanie leads our growing
marketing team which now
includes new faces in the UK,
Germany and USA to achieve
better access for FerriScan and
HepaFat-Scan to help improve
patient outcomes.
Melanie Baxter BA (hons)
UK Office
melanieb@resonancehealth.com
+44 (0) 759 892 9894
Tilo Stolzke
German Office
tilos@resonancehealth.com
+49 (0) 451 400 7684
Coming Soon...
{
Sickle Cell in Focus and BASL / Digestive Disorders Federation visit us at these conferences in London in June and see our conference
report next issue.
Click for further details of our upcoming events...
{
Partnering with the Thalassaemia International Federation to
improve health outcomes
{
Further R&D and study updates in next issue
Resonance Health
TWEET
278 Stirling Highway Claremont WA 6010 Australia
www.resonancehealth.com
FORWARD
You are receiving this email as you are registered in FAST or have
expressed interest in Resonance Health and/or our services
Preferences | Unsubscribe
https://remote.ferriscan.com/owa/?ae=Item&t=IPM.Note&id=RgAAAACaQFEzIhX6... 19/06/2015
Share your feedback
Discover